Marisa Rodriguez Wilson represents health care providers and other entities involved in the health care industry. With a wide range of experience, Marisa successfully provides guidance on complex regulatory, licensing, operational and compliance issues. She regularly assists clients with Medicare, Medicaid, Medicare Advantage and managed care initiatives and regulations.  

Marisa assists founder-based and other companies achieve strategic objectives through organic growth and acquisitions. She serves as lead regulatory counsel on healthcare transactions and performs due diligence reviews as part of acquisitions or to assist clients prepare for sale. She obtains approvals from regulatory agencies for changes of ownership and other transactional and corporate changes.

Marisa’s previous experience working at a multinational health care company, at a health care management services organization, and with large medical centers has provided her with a unique understanding of the legal and business matters that impact the health care sector. She utilizes her experience to best serve clients with strategic counsel.

Marisa is ranked by Chambers USA and in Best Lawyers in America. She is the current Board Chair for the American Red Cross Greater Miami and the Keys Chapter.

Education

  • St. Thomas University School of Law (J.D., 2006)
    • Nova Southeastern University (M.B.A., with honors, 1994)
      • Florida International University (B.S., 1992)
        • Industrial Engineering

      Bar Admission

      • Florida, 2006

      Professional Affiliations

      • American Red Cross Greater Miami & the Keys Chapter
        • Board Chair
        • Board of Directors
      • The Florida Bar, Health Law Section
      • American Health Lawyers Association
      • Home Care Association of Florida
      • Florida International University College of Medicine, Associate Professor of Medical Jurisprudence, 2010-2018
      • Susan B. Anthony Recovery Center, Executive Board Member, 2017-2018

      Recognition

      • Named to Florida Trend's Legal Elite - Notable Women Leaders in Law list, 2023-2025
      • Selected for inclusion in Best Lawyers in America® for Administrative/Regulatory Law, 2024-2026
      • Ranked in Chambers USA: America’s Leading Lawyers for Business, Healthcare, Florida, 2023-2025
      Publications
      Moratorium on New DME Medicaid Provider Enrollment in Florida
      Key Takeaways: Florida’s Agency for Healthcare Administration (AHCA) has implemented a six-month moratorium on the enrollment of new Durable Medical Equipment (DME) providers, effective March 20, 2026. The moratorium applies statewide and affects all new DME provider applications submitted after the effective date. Applications submitted prior to March 20 will continue to be processed. Pharmacies, hospitals and providers furnishing DME as a secondary service are not subject to the moratorium and may continue with enrollment. This action follows a similar federal moratorium from the Centers for Medicare & Medicaid Services (CMS) aimed at curbing fraud and protecting taxpayer resources, as Florida has been identified as a high-risk area for DME-related fraud. Effective March 20, 2026, Florida’s AHCA has implemented a statewide moratorium on the enrollment
      Read More
      Florida Legislative Session 2025: Health Care Highlights
      The Florida Regular Legislative Session began on March 4, 2025, and ended on June 6, 2025. Below is a summary of health care legislation scheduled to take effect upon becoming law, contingent on constitutional procedure. The most impactful bills are listed first. The remainder represent the broader balance of health care-related legislation passed during the 2025 session. 1. Medical Debt Bill HB 547 revises provisions relating to hospital and ambulatory surgical center (ASC) billing practices; expands the definition of extraordinary collection actions (ECAs) to actions for payment of any bill of care, including care outside of a hospital’s or ASC’s financial assistance policy; authorizes hospitals and ASCs to sell medical debt without providing 30-day notice if (1) the debt has no interest or
      Read More